Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

The combination treatment showed a higher response rate but no significant survival benefits.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Avacopan may cause unexpected side effects, so early monitoring is important.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Tangent screens help detect visual field defects from vigabatrin.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.